187 related articles for article (PubMed ID: 37735625)
1. Vitamin C may reduce troponin and CKMB levels after PCI and CABG: a meta-analysis.
Rozemeijer S; Hemilä H; van Baaren M; de Man AME
BMC Cardiovasc Disord; 2023 Sep; 23(1):475. PubMed ID: 37735625
[TBL] [Abstract][Full Text] [Related]
2. The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention.
Wang ZJ; Hu WK; Liu YY; Shi DM; Cheng WJ; Guo YH; Yang Q; Zhao YX; Zhou YJ
Can J Cardiol; 2014 Jan; 30(1):96-101. PubMed ID: 24365194
[TBL] [Abstract][Full Text] [Related]
3. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
Ben-Yehuda O; Chen S; Redfors B; McAndrew T; Crowley A; Kosmidou I; Kandzari DE; Puskas JD; Morice MC; Taggart DP; Leon MB; Lembo NJ; Brown WM; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
Eur Heart J; 2019 Jun; 40(24):1930-1941. PubMed ID: 30919909
[TBL] [Abstract][Full Text] [Related]
4. Periprocedural myocardial infarction is associated with increased mortality in patients with coronary artery bifurcation lesions after implantation of a drug-eluting stent.
Chen SL; Zhang JJ; Ye F; Tian NL; Sheiban I; Jepson N; Paiboon C; Sansoto T; Kwan TW; Wen SY; Wang HC; Jiang TM; Wang Y; Chen LL; Qiu CG; Zhang YJ; Chen MX; De Maria A
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():696-705. PubMed ID: 25631678
[TBL] [Abstract][Full Text] [Related]
5. Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: Results from a prospective, single center PCI registry.
Zhang Q; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Kirtane AJ; Zhang RY
Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():616-23. PubMed ID: 26864270
[TBL] [Abstract][Full Text] [Related]
6. Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization.
Gregson J; Stone GW; Ben-Yehuda O; Redfors B; Kandzari DE; Morice MC; Leon MB; Kosmidou I; Lembo NJ; Brown WM; Karmpaliotis D; Banning AP; Pomar J; Sabaté M; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Pocock SJ
J Am Coll Cardiol; 2020 Oct; 76(14):1609-1621. PubMed ID: 33004126
[TBL] [Abstract][Full Text] [Related]
7. Vitamin C for Cardiac Protection during Percutaneous Coronary Intervention: A Systematic Review of Randomized Controlled Trials.
Khan SA; Bhattacharjee S; Ghani MOA; Walden R; Chen QM
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32718091
[TBL] [Abstract][Full Text] [Related]
8. Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization.
Hara H; Serruys PW; Takahashi K; Kawashima H; Ono M; Gao C; Wang R; Mohr FW; Holmes DR; Davierwala PM; Head SJ; Thuijs DJFM; Milojevic M; Kappetein AP; Garg S; Onuma Y; Mack MJ;
J Am Coll Cardiol; 2020 Oct; 76(14):1622-1639. PubMed ID: 33004127
[TBL] [Abstract][Full Text] [Related]
9. Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions.
Cho MS; Ahn JM; Lee CH; Kang DY; Lee JB; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
JACC Cardiovasc Interv; 2017 Aug; 10(15):1498-1507. PubMed ID: 28797425
[TBL] [Abstract][Full Text] [Related]
10. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
[TBL] [Abstract][Full Text] [Related]
11. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial.
Hueb W; Gersh BJ; Rezende PC; Garzillo CL; Lima EG; Vieira RD; Garcia RM; Favarato D; Segre CA; Pereira AC; Soares PR; Ribeiro E; Lemos P; Perin MA; Strunz CC; Dallan LA; Jatene FB; Stolf NA; Hueb AC; Dias R; Gaiotto FA; da Costa LM; Oikawa FT; de Melo RM; Serrano CV; de Ávila LF; Villa AV; Filho JR; Nomura C; Ramires JA; Kalil Filho R;
BMC Cardiovasc Disord; 2012 Aug; 12():65. PubMed ID: 22898311
[TBL] [Abstract][Full Text] [Related]
12. Ten-year outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for multivessel or left main coronary artery disease: a systematic review and meta-analysis.
Feng S; Li M; Fei J; Dong A; Zhang W; Fu Y; Zhao Y
J Cardiothorac Surg; 2023 Feb; 18(1):54. PubMed ID: 36732810
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA
JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
Verdoia M; Ceccon C; Nardin M; Suryapranata H; De Luca G;
Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):744-750. PubMed ID: 29656938
[TBL] [Abstract][Full Text] [Related]
15. Coronary artery bypass graft surgery versus percutaneous coronary intervention with drug-eluting stents for left main coronary artery disease: A meta-analysis of randomized trials.
Putzu A; Gallo M; Martino EA; Ferrari E; Pedrazzini G; Moccetti T; Cassina T
Int J Cardiol; 2017 Aug; 241():142-148. PubMed ID: 28438354
[TBL] [Abstract][Full Text] [Related]
16. Prior Percutaneous Coronary Intervention and Mortality in Patients Undergoing Surgical Myocardial Revascularization: Results From the E-CABG (European Multicenter Study on Coronary Artery Bypass Grafting) With a Systematic Review and Meta-Analysis.
Mariscalco G; Rosato S; Serraino GF; Maselli D; Dalén M; Airaksinen JKE; Reichart D; Zanobini M; Onorati F; De Feo M; Gherli R; Santarpino G; Rubino AS; Gatti G; Nicolini F; Santini F; Perrotti A; Bruno VD; Ruggieri VG; Biancari F
Circ Cardiovasc Interv; 2018 Feb; 11(2):e005650. PubMed ID: 29440275
[TBL] [Abstract][Full Text] [Related]
17. Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCI.
Wang HY; Xu B; Dou K; Guan C; Song L; Huang Y; Zhang R; Xie L; Zhang M; Yan H; Yang W; Wu Y; Yang Y; Qiao S; Gao R; Stone GW
JACC Cardiovasc Interv; 2021 Aug; 14(15):1623-1634. PubMed ID: 34353593
[TBL] [Abstract][Full Text] [Related]
18. Troponin I elevation and cardiac events after percutaneous coronary intervention.
Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO
Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.
Peivandi AA; Dahm M; Opfermann UT; Peetz D; Doerr F; Loos A; Oelert H
Herz; 2004 Nov; 29(7):658-64. PubMed ID: 15580320
[TBL] [Abstract][Full Text] [Related]
20. Use of cardiac troponin I to diagnose perioperative myocardial infarction in coronary artery bypass grafting.
Mair J; Larue C; Mair P; Balogh D; Calzolari C; Puschendorf B
Clin Chem; 1994 Nov; 40(11 Pt 1):2066-70. PubMed ID: 7955380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
